Dr Agarwals Eye Hospital Limited provides specialized eye care services, operating at quarterly revenue scale of ₹75–102 Cr. The company demonstrates strong capital efficiency with 29.8% ROE and sustained 26–31% operating margins, positioning it as a profitable player in the healthcare services sector.
Generated analysis · source review pending
Generated analysis · source review pending
2,370 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Standalone figures
| Ratio | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | 88.4% | 88.6% | — | 89.4% | 89.4% | 90% |
| EBITDA margin % | 17% | 26.3% | 21.7% | 28.7% | 27.9% | 28.5% | 29.8% | 30.9% |
| EBIT margin % | 10.6% | 14.2% | 8.1% | 18.5% | 20.3% | 20.2% | 19.9% | 21.2% |
| PAT margin % | 7% | 7.8% | -1% | 12% | 13.8% | 14.5% | 13.8% | 14.9% |
| Working capital | ||||||||
| Receivable days | 19 | 14 | 23 | 16 | — | 15 | 13 | — |
| Inventory days | 17 | 22 | 117 | 91 | — | 106 | 117 | — |
| Payable days | — | — | 401 | 410 | — | 345 | 263 | — |
| NWC days | — | — | -261 | -302 | — | -224 | -133 | — |
| Leverage | ||||||||
| Current ratio | 0.84 | 0.75 | 0.91 | 0.94 | — | 0.74 | 0.64 | — |
| Debt to EBITDA | 0.63 | 0.29 | 0.71 | 0.55 | — | 0.56 | 0.81 | — |
| Debt to equity | 0.4 | 0.24 | 0.4 | 0.41 | — | 0.33 | 0.46 | — |
| Interest coverage | 7.8 | 3.6 | 1.9 | 6.2 | 8.2 | 9.7 | 6.3 | 8.9 |
| Asset turnover | 1.7 | 1.25 | 0.9 | 0.64 | — | 0.64 | 0.65 | — |
| Return ratios | ||||||||
| Return on assets % | 11.9% | 9.7% | -0.9% | 7.7% | — | 9.4% | 8.9% | — |
| Return on capital employed % | 36.8% | 33.2% | 11.6% | 21% | — | 16.7% | 17.9% | — |
| Return on equity % | 26.1% | 24.4% | -2.6% | 30.8% | — | 29.5% | 26.1% | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 72.67% | 72.67% | 72.67% | 72.67% | |
| 0.28% | 0.63% | 0.64% | 0.65% | 0.83% | 0.84% | 1.33% | 1.5% | 1.74% | 1.82% | 2.2% | 2.24% | |
| 0% | 0% | 0% | 0% | 0.96% | 1.03% | 1.95% | 2.31% | 2.36% | 2.36% | 2.12% | 2.05% | |
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| 27.82% | 27.47% | 27.46% | 27.45% | 26.31% | 26.23% | 24.82% | 24.29% | 23.23% | 23.15% | 23.01% | 23.04% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 30,528 | 25,449 | 24,036 | 22,954 |
Promoter holding up 0.77 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 3 Mar 2025 | MALABAR INDIA FUND LIMITED | Bulk | BSE | Buy | 54,000 | ₹3,707.00 | ₹20.02 Cr |
| 3 Mar 2025 | KIFTAR IN LLC | Bulk | BSE | Sell | 42,247 | ₹3,707.00 | ₹15.66 Cr |
| 8 Dec 2021 | SUNITA AGARWAL . | Bulk | BSE | Sell | 23,841 | ₹787.42 | ₹1.88 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Documents link to external sources (exchange filings, company investor pages).
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Newspaper Publication
32Nd Annual General Meeting Of The Members Of The Company- September 09, 2026
Intimation Of Record Date Under Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Reg. 34 (1) Annual Report.
| Date | Category | Subject | Filing |
|---|---|---|---|
| 28 Sept 2026, 1:44 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window | |
| 10 Sept 2026, 1:16 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | |
| 9 Sept 2026, 6:21 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Outcome of AGM | |
| 27 Aug 2026, 3:39 pm | Company Update Press Release / Media Release | Announcement under Regulation 30 (LODR)-Press Release / Media Release | |
| 15 Aug 2026, 4:35 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication | |
| 14 Aug 2026, 6:45 pm | AGM/EGM AGM | 32Nd Annual General Meeting Of The Members Of The Company- September 09, 2026 | |
| 14 Aug 2026, 6:42 pm | Corp. Action Record Date | Intimation Of Record Date Under Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | |
| 14 Aug 2026, 6:38 pm | Others Reg. 34 (1) Annual Report | Reg. 34 (1) Annual Report. |
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH | ₹91,573 Cr | ₹95,052 Cr | ₹8,712 Cr | ₹2,318 Cr | 26.8% | ₹1,457 Cr | 17.2% | 13.8% | 14.3% | -110 |
| Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS | ₹91,552 Cr | ₹1,02,105 Cr | ₹10,336 Cr | ₹2,611 Cr | 25.3% | ₹917 Cr | 8.9% | 12.5% | 12.8% | 38 |
| Fortis Healthcare LimitedFORTISFORTIS | ₹59,268 Cr | ₹62,140 Cr | ₹9,506 Cr | ₹2,131 Cr | 22.8% | ₹1,048 Cr | 11.7% | 13% | 11.1% | -99 |
| Aster Dm Healthcare LimitedASTERDMASTERDM | ₹36,728 Cr | ₹37,429 Cr | ₹4,876 Cr | ₹958 Cr | 19.4% | ₹319 Cr | 9.2% | 11.9% | 9.7% | -112 |
| Global Health LimitedMEDANTAMEDANTA | ₹36,498 Cr | ₹37,688 Cr | ₹4,683 Cr | ₹979 Cr | 20.8% | ₹556 Cr | 12.6% | 16.9% | 15.1% | -26 |
| Narayana Hrudayalaya Ltd.NHNH | ₹35,594 Cr | ₹40,460 Cr | ₹9,072 Cr | ₹1,749 Cr | 20.5% | ₹816 Cr | 10.2% | 15.1% | 19.7% | -181 |
| Krishna Institute Of Medical Sciences LimitedKIMSKIMS | ₹29,457 Cr | ₹32,701 Cr | ₹4,213 Cr | ₹833 Cr | 20.5% | ₹205 Cr | 6.2% | 9.5% | 11% | -50 |
| Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE | ₹15,420 Cr | ₹15,578 Cr | ₹2,207 Cr | ₹612 Cr | 27.4% | ₹148 Cr | 8.1% | 10.1% | 6.8% | -76 |
| Rainbow Childrens Medicare LimitedRAINBOWRAINBOW | ₹13,003 Cr | ₹13,003 Cr | ₹1,820 Cr | ₹575 Cr | 32% | ₹285 Cr | 16.5% | 18.2% | 17.9% | -73 |
| Park Medi World LimitedPARKHOSPSPARKHOSPS | ₹11,696 Cr | ₹11,924 Cr | ₹1,679 Cr | ₹444 Cr | 26.5% | ₹258 Cr | 16.3% | 21.4% | 16.7% | -2 |
| Healthcare Global Enterprises LimitedHCGHCG | ₹9,984 Cr | ₹10,895 Cr | ₹2,627 Cr | ₹480 Cr | 18.3% | ₹23 Cr | 0.9% | 9.1% | 1.2% | -93 |
| Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH | ₹9,965 Cr | ₹10,218 Cr | ₹1,334 Cr | ₹310 Cr | 24.2% | ₹174 Cr | 14.1% | 12.3% | 10% | -26 |
1 schemes
| Shares | ||||||
|---|---|---|---|---|---|---|
| (Investment Manager for Motilal Oswal Mutual Fund) | Motilal Oswal Mutual Fund | 33 | 0.02 | 0.04% | 0.001% | -0 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 135 | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 319 | 397 | 471 | |
| COGS | — | — | -28 | -27 | -32 | 16 | 23 | -30 | 34 | 42 | 47 |
| Gross profit | — | — | — | — | — | 124 | 178 | — | 286 | 355 | 424 |
| 134 | 136 | 158 | 168 | 162 | 93 | 121 | 223 | 195 | 237 | 279 | |
| Operating profit (EBITDA) | 2 | 13 | 23 | 29 | 46 | 30 | 58 | 75 | 91 | 119 | 145 |
| OPM % | 1.1% | 8.6% | 15.3% | 17% | 26.3% | 21.7% | 28.7% | 27.9% | 28.5% | 29.8% | 30.9% |
| Depreciation | — | — | 10 | 11 | 21 | 19 | 20 | 20 | 27 | 39 | 46 |
| Interest | 4 | 3 | 3 | 3 | 8 | 6 | 6 | 7 | 7 | 13 | 12 |
| 1 | 0 | 2 | 2 | 3 | 1 | 1 | 2 | 5 | 5 | 6 | |
| Profit before tax | -0 | 10 | 13 | 17 | 20 | 6 | 32 | 49 | 62 | 71 | 94 |
| Tax | -1 | 3 | 7 | 6 | 6 | 7 | 8 | 12 | 16 | 16 | 24 |
| Tax % | -110.4% | 33% | 49.3% | 31.6% | 31.4% | 125.1% | 25.4% | 25.3% | 25.5% | 22.7% | 25.1% |
| 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 70 | |
| PAT margin % | 0% | 4.4% | 4.4% | 7% | 7.8% | -1% | 12% | 13.8% | 14.5% | 13.8% | 14.9% |
| EPS (₹) | 0.1 | 14 | 14.4 | 25.4 | 29.1 | -3.1 | 51.3 | 78.6 | 98.6 | 116.3 | — |
| EPS adjusted (₹) | 0.1 | 14 | 14.4 | 25.4 | 29.1 | -3.1 | 51.3 | 78.6 | 98.6 | 116.3 | — |
| 1,000% | 10.7% | 8.3% | 5.9% | 0% | — | 5.8% | 3.8% | 5.1% | 5.2% | — | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 19 | 18 | 30 | 41 | 51 | 50 | 73 | — | 152 | 205 |
| 24 | 24 | 10 | 18 | 13 | 22 | 32 | — | 51 | 96 | |
| 31 | 31 | 36 | 36 | 71 | 79 | 204 | — | 287 | 307 | |
| Total equity & liabilities | 79 | 77 | 81 | 100 | 141 | 155 | 314 | — | 496 | 613 |
| 34 | 34 | 36 | 55 | 57 | 96 | 214 | 260 | 316 | 393 | |
| CWIP | 1 | 1 | 3 | 0 | 0 | 0 | 26 | — | 97 | 128 |
| Investments | — | — | — | — | — | 0 | 0 | — | 0 | 13 |
| 44 | 43 | 42 | 45 | 84 | 60 | 73 | — | 83 | 80 | |
| Total assets | 79 | 77 | 81 | 100 | 141 | 155 | 314 | — | 496 | 613 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 94 | 145 | |
| -17 | -8 | -11 | -17 | -17 | -11 | -46 | -71 | -70 | -133 | -174 | |
| -0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 | 25 | |
| Net cash flow | 0 | 0 | -0 | — | 2 | 15 | 7 | -1 | 6 | -22 | -4 |
| Free cash flow | — | — | 7 | 26 | — | 23 | 10 | — | 18 | -8 | — |
| CFO / Operating profit % | — | 157.9% | 79.2% | 86.7% | 83.6% | 111.5% | 98.3% | 93.2% | 98.6% | 79.7% | 99.9% |